DISCOUNT ZERTIFIKAT - ASTRAZENECA | Real-time Boerse Frankfurt Warrants 03:20:19 2024-05-29 am EDT | ||
| 111.3 EUR | +0.13% |
|
| Current month | +0.80% | ||
| 1 month | +1.31% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
| Date | Price | Change |
|---|---|---|
| 24-05-29 | 111.3 | +0.13% |
| 24-05-28 | 111.2 | +0.08% |
| 24-05-24 | 111.1 | +0.06% |
| 24-05-23 | 111 | -0.03% |
| 24-05-22 | 111 | +0.30% |
Real-time Boerse Frankfurt Warrants
Last update May 29, 2024 at 03:20 am EDT
More quotesStatic data
| Product type | Certificats Discount |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | 
BNP Paribas
|
| WKN | PC3VYM |
| ISIN | DE000PC3VYM3 |
| Date issued | 2024-01-25 |
| Cap | 9,500 p |
| Last trading day | 2024-06-21 |
| Maturity | 2024-06-21 (24 Days) |
| Parity | 1 : 1 |
| Emission price | 106.3 € |
| Emission volume | N/A |
| Payment day | 2024-06-27 |
| Bonus | - € |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Discount (ask) | 21.54 % |
|---|---|
| Sideways yield | 0.5687 % |
| Sideways yield pa | 9.024 % |
| Outperformance point | 12,108 p |
| Break even | 9,446.28 € |
| Highest since issue | 111.3 € |
| Lowest since issue | 104.4 € |
| Spread | 0.05 € |
| Spread % | 0.04% |
| Distance Cap | 2,514 p |
| Distance Cap % | +20.93% |
| Max. earning | 0.633 |
| Max. earning % | 0.5687 % |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
153.7
USD
Average target price
170.1
USD
Spread / Average Target
+10.69%
- Stock Market
- Certificates
- Certificat
